ARVEE
Arvee Laboratories (India) financials
- Market cap
- ₹199 Cr
- Sector
- Chemicals
What Arvee Laboratories (India) Limited does
Arvee Laboratories (India) Limited is a Gujarat-based company in the speciality chemicals space, with a director's role dedicated to bringing in new international raw-material suppliers and to identifying customers for the company's products abroad. This points to a business that both imports key inputs and exports its finished chemical products internationally.
Quarterly results
Q1 FY27: revenue up 130.3%, net profit up 894.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13 | 9 | 6 | 7 | 3 −72% | 10 +10% | 11 +67% | 17 +130% |
| EBITDA | 2 | 0 | 0 | 0 | 0 −92% | 2 +379% | 1 +400% | 2 +632% |
| Net profit | 1 | 0 | 0 | 0 | 0 −99% | 2 +1120% | 1 +643% | 2 +894% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +15.2% 1Y
1Y: ₹156.85 on 10 Sept 2025 → ₹180.69. High ₹290.78 (19 Dec 2025), low ₹133.86 (30 Mar 2026).
Financials, as filed
Revenue fell 23.3% a year over 3 years, FY23 to FY26. Operating margin narrowed to 10.1%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹70 Cr | ₹30 Cr | ₹38 Cr | ₹32 Cr |
| Operating profit | ₹8 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr |
| Operating margin | 12.1% | 9.9% | 9.4% | 10.1% |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹4 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr |
| Net margin | 5.9% | 3.5% | 5.6% | 8.0% |
| Cash from operations | ₹3 Cr | ₹4 Cr | ₹-0 Cr | ₹-0 Cr |
| Free cash flow | ₹1 Cr | ₹1 Cr | ₹-2 Cr | ₹-3 Cr |
| ROCE | 23.3% | 6.8% | 9.6% | 7.5% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
| Reserves | ₹10 Cr | ₹13 Cr | ₹17 Cr | ₹18 Cr | ₹20 Cr | ₹23 Cr |
| Borrowings | ₹9 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Other liabilities | ₹11 Cr | ₹12 Cr | ₹10 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr |
| Total liabilities | ₹41 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹41 Cr | ₹43 Cr |
| Fixed assets | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹15 Cr | ₹17 Cr |
| Capital work in progress | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr |
| Investments | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| Other assets | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹23 Cr | ₹25 Cr | ₹24 Cr |
| Total assets | ₹41 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹41 Cr | ₹43 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count grew 6% to 1,596.
- Promoters
- 73.5%
- Public
- 26.5%
Since Jun 2025
- Promoters 0.00 pp
- Public 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 73.5%, Public 26.5%.Dec '23: Promoters 73.5%, Public 26.5%.Mar '24: Promoters 73.5%, Public 26.5%.Jun '24: Promoters 73.5%, Public 26.5%.Sep '24: Promoters 73.5%, Public 26.5%.Dec '24: Promoters 73.5%, Public 26.5%.Mar '25: Promoters 73.5%, Public 26.5%.Jun '25: Promoters 73.5%, Public 26.5%.Sep '25: Promoters 73.5%, Public 26.5%.Dec '25: Promoters 73.5%, Public 26.5%.Mar '26: Promoters 73.5%, Public 26.5%.Jun '26: Promoters 73.5%, Public 26.5%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Arvee Laboratories (India) Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Shalin Sudhakarbhai Patel | 36.68% | unchanged |
| Mitaben Bharatbhai Chokshi | 24.57% | unchanged |
| Kavita Shalin Chokshi | 12.16% | unchanged |
| Gitaben Dinehsbhai Patel | 9.98% | unchanged |
| Deval Pranav Patel | 5.19% | unchanged |
| Jashbhai Patel | 4.79% | unchanged |
| Madhuben Jashbhai Patel | 3.70% | unchanged |
| Key Managerial Personnel | 0.04% | unchanged |
| Chandrabalaben Patel | 0.02% | unchanged |
| Shalinbhai Sudhakarbhai Patel Huf | 0.02% | unchanged |
| Sudhakar Chhotabhai Patel Huf | 0.02% | unchanged |
| Khushbuben Shalinbhai Patel | 0.02% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Arvee Laboratories (India) Limited
Guides on how to read this kind of business and the numbers that matter.